Skip to main content
Erschienen in: Skeletal Radiology 12/2023

07.08.2023 | Case Report

Recurrent chondromyxoid fibroma of the distal femur treated with percutaneous cryoablation

verfasst von: Prateek C. Gowda, Robert H. Dunlap, Shivani Ahlawat, John M. Gross, Carol D. Morris, Gray R. Lyons

Erschienen in: Skeletal Radiology | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Chondromyxoid fibroma is a rare, benign tumor of the bone with excellent prognosis but a high rate of recurrence. We report a patient presenting with pain and a history of chondromyxoid fibroma of the distal left femur previously treated with multiple prior curettage and bone graft procedures. Magnetic resonance imaging and histopathology indicated a recurrence of tumor. Due to the small size of the tumor recurrence and challenges associated with prior open surgery, the patient underwent cryoablation of the lesion with computed tomography guidance. Follow-up 18 months later indicated a resolution of pain and improvement on magnetic resonance imaging, and no concerns after 20 months. To our knowledge, this is the first reported case of chondromyxoid fibroma treated with cryoablation. This case suggests cryoablation could be considered in the setting of recurrent chondromyxoid fibroma for local tumor control.
Literatur
1.
Zurück zum Zitat Jaffe HL, Lichtenstein L. Chondromyxoid fibroma of bone; a distinctive benign tumor likely to be mistaken especially for chondrosarcoma. Arch Pathol. 1948;45(4):541–51. Jaffe HL, Lichtenstein L. Chondromyxoid fibroma of bone; a distinctive benign tumor likely to be mistaken especially for chondrosarcoma. Arch Pathol. 1948;45(4):541–51.
2.
Zurück zum Zitat Tu WC, Inwards CY, O’laughlin S, Rock MG, Beabout JW, Unni KK. Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases. Hum Pathol. 1998;29(5):438–46.CrossRef Tu WC, Inwards CY, O’laughlin S, Rock MG, Beabout JW, Unni KK. Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases. Hum Pathol. 1998;29(5):438–46.CrossRef
3.
Zurück zum Zitat Heck RK, Toy PC, et al. Benign/aggressive tumors of bone. In: Azar FM, Beaty JH, et al., editors. Campbell’s Operative Orthopaedics. 13th ed. Philadelphia: Elsevier; 2017. p. 923–44.e3. Heck RK, Toy PC, et al. Benign/aggressive tumors of bone. In: Azar FM, Beaty JH, et al., editors. Campbell’s Operative Orthopaedics. 13th ed. Philadelphia: Elsevier; 2017. p. 923–44.e3.
4.
Zurück zum Zitat Cappelle S, Pans S, Sciot R. Imaging features of chondromyxoid fibroma: report of 15 cases and literature review. Br J Radiol. 2016;89(1064):20160088.CrossRefPubMedPubMedCentral Cappelle S, Pans S, Sciot R. Imaging features of chondromyxoid fibroma: report of 15 cases and literature review. Br J Radiol. 2016;89(1064):20160088.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Yalniz E, Alicioglu B, Yalcin O, Yilmaz B. Non specific magnetic resonance features of chondromyxoid fibroma of the iliac bone. Journal of BU ON. 2007;12(3):407–9. Yalniz E, Alicioglu B, Yalcin O, Yilmaz B. Non specific magnetic resonance features of chondromyxoid fibroma of the iliac bone. Journal of BU ON. 2007;12(3):407–9.
6.
Zurück zum Zitat Mitchell M, Sartoris DJ, Resnick D. Case report 713. Chondromyxoid fibroma of the third metatarsal. Skeletal Radiol. 1992;21(4):252–5.PubMed Mitchell M, Sartoris DJ, Resnick D. Case report 713. Chondromyxoid fibroma of the third metatarsal. Skeletal Radiol. 1992;21(4):252–5.PubMed
7.
Zurück zum Zitat Layfield LJ. Cytopathology of bone and soft tissue tumors. Oxford: Oxford Univ. Press; 2002. Layfield LJ. Cytopathology of bone and soft tissue tumors. Oxford: Oxford Univ. Press; 2002.
8.
Zurück zum Zitat Damle RP, Suryawanshi KH, Dravid NV, Gadre A, Borse YM. Chondromyxoid fibroma of bone. Journal of Case Reports. 2013;3(2):228–31.CrossRef Damle RP, Suryawanshi KH, Dravid NV, Gadre A, Borse YM. Chondromyxoid fibroma of bone. Journal of Case Reports. 2013;3(2):228–31.CrossRef
9.
Zurück zum Zitat Schajowicz F, Gallardo H. Chondromyxoid fibroma (fibromyxoid chondroma) of bone. A clinico-pathological study of thirty-two cases. J Bone and Joint Surg Br Vol. 1971;53(2):198–216.CrossRef Schajowicz F, Gallardo H. Chondromyxoid fibroma (fibromyxoid chondroma) of bone. A clinico-pathological study of thirty-two cases. J Bone and Joint Surg Br Vol. 1971;53(2):198–216.CrossRef
10.
Zurück zum Zitat Rahimi A, Beabout JW, Ivins JC, Dahlin DC. Chondromyxoid fibroma: a clinicopathologic study of 76 cases. Cancer. 1972;30(3):726–36.CrossRefPubMed Rahimi A, Beabout JW, Ivins JC, Dahlin DC. Chondromyxoid fibroma: a clinicopathologic study of 76 cases. Cancer. 1972;30(3):726–36.CrossRefPubMed
11.
Zurück zum Zitat Horstmann PF, Hettwer WH, Petersen MM. Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction. J Orthop Surg. 2018;26(3):2309499018774929.CrossRef Horstmann PF, Hettwer WH, Petersen MM. Treatment of benign and borderline bone tumors with combined curettage and bone defect reconstruction. J Orthop Surg. 2018;26(3):2309499018774929.CrossRef
12.
Zurück zum Zitat Berenstein-Weyel T, Lebel E, Katz D, Applbaum Y, Peyser A. Chondromyxoid fibroma of the distal fibula treated by percutaneous radiofrequency ablation. J Orthop Surg. 2017;25(2):2309499017720830.CrossRef Berenstein-Weyel T, Lebel E, Katz D, Applbaum Y, Peyser A. Chondromyxoid fibroma of the distal fibula treated by percutaneous radiofrequency ablation. J Orthop Surg. 2017;25(2):2309499017720830.CrossRef
13.
Zurück zum Zitat Foster RCB, Stavas JM. Bone and soft tissue ablation. Semin Interv Radiol. 2014;31(2):167–79.CrossRef Foster RCB, Stavas JM. Bone and soft tissue ablation. Semin Interv Radiol. 2014;31(2):167–79.CrossRef
14.
Zurück zum Zitat Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.CrossRefPubMed Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.CrossRefPubMed
15.
Zurück zum Zitat Tomasian A, Cazzato RL, Sharma K, Gangi A, Jennings JW. Benign bone tumors: state of the art in minimally invasive percutaneous interventions. Radiographics. 2023;43(2):e220041.CrossRefPubMed Tomasian A, Cazzato RL, Sharma K, Gangi A, Jennings JW. Benign bone tumors: state of the art in minimally invasive percutaneous interventions. Radiographics. 2023;43(2):e220041.CrossRefPubMed
16.
Zurück zum Zitat Le Corroller T, Vives T, Mattei J, Pauly V, Guenoun D, Rochwerger A, et al. Osteoid osteoma: percutaneous CT-guided cryoablation is a safe, effective, and durable treatment option in adults. Radiology. 2022;302(2):392–9.CrossRefPubMed Le Corroller T, Vives T, Mattei J, Pauly V, Guenoun D, Rochwerger A, et al. Osteoid osteoma: percutaneous CT-guided cryoablation is a safe, effective, and durable treatment option in adults. Radiology. 2022;302(2):392–9.CrossRefPubMed
17.
Zurück zum Zitat Colangeli S, Parchi P, Andreani L, Beltrami G, Scoccianti G, Sacchetti F, et al. Cryotherapy efficacy and safety as local therapy in surgical treatment of musculoskeletal tumours. A retrospective case series of 143 patients. J Biol Regul Homeost Agents. 2018;32(6 Suppl. 1):65–70.PubMed Colangeli S, Parchi P, Andreani L, Beltrami G, Scoccianti G, Sacchetti F, et al. Cryotherapy efficacy and safety as local therapy in surgical treatment of musculoskeletal tumours. A retrospective case series of 143 patients. J Biol Regul Homeost Agents. 2018;32(6 Suppl. 1):65–70.PubMed
18.
Zurück zum Zitat Fritz J, Sonnow L, Morris CD. Adjuvant MRI-guided percutaneous cryoablation treatment for aneurysmal bone cyst. Skeletal Radiol. 2019;48(7):1149–53.CrossRefPubMed Fritz J, Sonnow L, Morris CD. Adjuvant MRI-guided percutaneous cryoablation treatment for aneurysmal bone cyst. Skeletal Radiol. 2019;48(7):1149–53.CrossRefPubMed
19.
Zurück zum Zitat Zivin SP, Gaba RC. Technical and practical considerations for device selection in locoregional ablative therapy. Semin Interv Radiol. 2014;31(2):212–24.CrossRef Zivin SP, Gaba RC. Technical and practical considerations for device selection in locoregional ablative therapy. Semin Interv Radiol. 2014;31(2):212–24.CrossRef
20.
Zurück zum Zitat Callstrom M, Kurup A. Percutaneous ablation for bone and soft tissue metastases—why cryoablation? Skeletal Radiol. 2009;38(9):835–9.CrossRefPubMed Callstrom M, Kurup A. Percutaneous ablation for bone and soft tissue metastases—why cryoablation? Skeletal Radiol. 2009;38(9):835–9.CrossRefPubMed
21.
Zurück zum Zitat Auloge P, Cazzato RL, Rousseau C, Caudrelier J, Koch G, Rao P, et al. Complications of percutaneous bone tumor cryoablation: a 10-year experience. Radiology. 2019;291(2):521–8.CrossRefPubMed Auloge P, Cazzato RL, Rousseau C, Caudrelier J, Koch G, Rao P, et al. Complications of percutaneous bone tumor cryoablation: a 10-year experience. Radiology. 2019;291(2):521–8.CrossRefPubMed
Metadaten
Titel
Recurrent chondromyxoid fibroma of the distal femur treated with percutaneous cryoablation
verfasst von
Prateek C. Gowda
Robert H. Dunlap
Shivani Ahlawat
John M. Gross
Carol D. Morris
Gray R. Lyons
Publikationsdatum
07.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 12/2023
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-023-04414-4

Weitere Artikel der Ausgabe 12/2023

Skeletal Radiology 12/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.